Dingdang Health logs 28,500-share buyback on 1 Apr; cumulative repurchases reach 27.69 million shares, 2.10% of capital

Bulletin Express04-01

Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (1 April 2026) confirming continued share repurchase activity under its current mandate while leaving total issued share capital unchanged.

Key points 1. Capital structure unchanged • Issued shares (excluding treasury shares) stood at 1,319.47 million both before and after the latest transaction. • The company holds no treasury shares.

2. 1 April 2026 repurchase details • Volume: 28,500 ordinary shares, to be cancelled. • Venue: Hong Kong Stock Exchange. • Price range: HKD 0.91–0.92 per share. • Total consideration: HKD 26,159.80.

3. Cumulative activity under 2025–26 mandate • Shareholders renewed the buyback mandate on 28 May 2025 for up to 131.95 million shares. • Between 25 Nov 2025 and 1 Apr 2026, the company has repurchased 27.69 million shares in 44 separate on-market trades. • The aggregated volume represents approximately 2.10% of the company’s issued share capital as of the mandate date, utilising roughly 21.00% of the authorised limit. • Transaction prices during the period ranged from HKD 0.80 to HKD 1.21 per share.

4. Moratorium on new issues In line with Hong Kong listing rules, Dingdang Health is restricted from issuing new shares or disposing of treasury shares until 1 May 2026.

All repurchases have been authorised by the board and executed in compliance with Hong Kong Stock Exchange regulations, and the company confirms receipt of all monies due from the transactions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155566629?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 19:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155566629","market":"us","top_or_hot":-1,"title":"Dingdang Health logs 28,500-share buyback on 1 Apr; cumulative repurchases reach 27.69 million shares, 2.10% of capital","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (1 April 2026) confirming continued share repurchase activity under its current mandate while leaving total issued share capital unchanged.</p>\n<p>Key points  \n1. Capital structure unchanged  \n• Issued shares (excluding treasury shares) stood at 1,319.47 million both before and after the latest transaction.  \n• The company holds no treasury shares.</p>\n<p>2. 1 April 2026 repurchase details  \n• Volume: 28,500 ordinary shares, to be cancelled.  \n• Venue: Hong Kong Stock Exchange.  \n• Price range: HKD 0.91–0.92 per share.  \n• Total consideration: HKD 26,159.80.</p>\n<p>3. Cumulative activity under 2025–26 mandate  \n• Shareholders renewed the buyback mandate on 28 May 2025 for up to 131.95 million shares.  \n• Between 25 Nov 2025 and 1 Apr 2026, the company has repurchased 27.69 million shares in 44 separate on-market trades.  \n• The aggregated volume represents approximately 2.10% of the company’s issued share capital as of the mandate date, utilising roughly 21.00% of the authorised limit.  \n• Transaction prices during the period ranged from HKD 0.80 to HKD 1.21 per share.</p>\n<p>4. Moratorium on new issues  \nIn line with Hong Kong listing rules, Dingdang Health is restricted from issuing new shares or disposing of treasury shares until 1 May 2026.</p>\n<p>All repurchases have been authorised by the board and executed in compliance with Hong Kong Stock Exchange regulations, and the company confirms receipt of all monies due from the transactions.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health logs 28,500-share buyback on 1 Apr; cumulative repurchases reach 27.69 million shares, 2.10% of capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health logs 28,500-share buyback on 1 Apr; cumulative repurchases reach 27.69 million shares, 2.10% of capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-01 19:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (1 April 2026) confirming continued share repurchase activity under its current mandate while leaving total issued share capital unchanged.</p>\n<p>Key points  \n1. Capital structure unchanged  \n• Issued shares (excluding treasury shares) stood at 1,319.47 million both before and after the latest transaction.  \n• The company holds no treasury shares.</p>\n<p>2. 1 April 2026 repurchase details  \n• Volume: 28,500 ordinary shares, to be cancelled.  \n• Venue: Hong Kong Stock Exchange.  \n• Price range: HKD 0.91–0.92 per share.  \n• Total consideration: HKD 26,159.80.</p>\n<p>3. Cumulative activity under 2025–26 mandate  \n• Shareholders renewed the buyback mandate on 28 May 2025 for up to 131.95 million shares.  \n• Between 25 Nov 2025 and 1 Apr 2026, the company has repurchased 27.69 million shares in 44 separate on-market trades.  \n• The aggregated volume represents approximately 2.10% of the company’s issued share capital as of the mandate date, utilising roughly 21.00% of the authorised limit.  \n• Transaction prices during the period ranged from HKD 0.80 to HKD 1.21 per share.</p>\n<p>4. Moratorium on new issues  \nIn line with Hong Kong listing rules, Dingdang Health is restricted from issuing new shares or disposing of treasury shares until 1 May 2026.</p>\n<p>All repurchases have been authorised by the board and executed in compliance with Hong Kong Stock Exchange regulations, and the company confirms receipt of all monies due from the transactions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1155566629","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155566629","pubTimestamp":1775041526,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (1 April 2026) confirming continued share repurchase activity under its current mandate while leaving total issued share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康于4月1日回购28,500股；累计回购达2769万股，占股本的2.10%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (1 April 2026) confirming continued share repurchase activity under its current mandate while leaving total issued share capital unchanged.\nKey points  \n1. Capital structure unchanged  \n• Issued shares (excluding treasury shares) stood at 1,319.47 million both before and after the latest transaction.  \n• The company holds no treasury shares.\n2. 1 April 2026 repurchase details  \n• Volume: 28,500 ordinary shares, to be cancelled.  \n• Venue: Hong Kong Stock Exchange.  \n• Price range: HKD 0.91–0.92 per share.  \n• Total consideration: HKD 26,159.80.\n3. Cumulative activity under 2025–26 mandate  \n• Shareholders renewed the buyback mandate on 28 May 2025 for up to 131.95 million shares.  \n• Between 25 Nov 2025 and 1 Apr 2026, the company has repurchased 27.69 million shares in 44 separate on-market trades.  \n• The aggregated volume represents approximately 2.10% of the company’s issued share capital as of the mandate date, utilising roughly 21.00% of the authorised limit.  \n• Transaction prices during the period ranged from HKD 0.80 to HKD 1.21 per share.\n4. Moratorium on new issues  \nIn line with Hong Kong listing rules, Dingdang Health is restricted from issuing new shares or disposing of treasury shares until 1 May 2026.\nAll repurchases have been authorised by the board and executed in compliance with Hong Kong Stock Exchange regulations, and the company confirms receipt of all monies due from the transactions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155566629","isCrawlerRequest":true}